Low-dose inhaled versus standard dose oral form of anti-tubercular drugs: concentrations in bronchial epithelial lining fluid, alveolar macrophage and serum.
Katiyar
S K
SK
Bihari
S
S
Prakash
S
S
D000280:Administration, Inhalation; D000284:Administration, Oral; D000328:Adult; D000995:Antitubercular Agents / Q000008:administration & dosage* / Q000097:blood*; D001992:Bronchoalveolar Lavage Fluid / Q000737:chemistry*; D004305:Dose-Response Relationship, Drug; D004848:Epithelium / Q000378:metabolism; D005260:Female; D006801:Humans; D007538:Isoniazid / Q000008:administration & dosage / Q000097:blood*; D016676:Macrophages, Alveolar / Q000737:chemistry*; D008297:Male; D008875:Middle Aged; D009092:Mucous Membrane / Q000378:metabolism; D011718:Pyrazinamide / Q000008:administration & dosage / Q000097:blood*; D012293:Rifampin / Q000008:administration & dosage / Q000097:blood*; D055815:Young Adult
D000995:Antitubercular Agents; D011718:Pyrazinamide; D007538:Isoniazid; D012293:Rifampin